[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cogent Biosciences Inc 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 USA

www.cogentbio.com Employees: 258 P: 617-945-5576

Sector:

Medical

Description:

Cogent Biosciences Inc. is a biotechnology company. It is focused on developing precision therapies for genetically defined diseases. The company's program consist PLX9486. Cogent Biosciences Inc., formerly known as Unum Therapeutics Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 5,961,610
Enterprise Value, $K 5,961,890
Shares Outstanding, K 162,309
Float, K 150,477
% Float 92.71%
Short Interest, K 17,426
Short Float 10.74%
Days to Cover 7.10
Short Volume Ratio 0.31
% of Insider Shareholders 7.29%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -328,940 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -102,490 K
EBIT, $ -333,360 K
EBITDA, $ -332,160 K

Growth:

1-Year Return 743.55%
3-Year Return 241.36%
5-Year Return 322.67%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 86.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.55 on 02/17/26
Next Earnings Date 05/05/26 [--]
Earnings Per Share ttm -2.10
EPS Growth vs. Prev Qtr -10.00%
EPS Growth vs. Prev Year -511.11%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 11/09/20

COGT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -143.09%
Return-on-Assets % -66.96%
Profit Margin % 0.00%
Debt/Equity 0.35
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 9.63
Book Value/Share 4.47
Interest Coverage -106.50
60-Month Beta 0.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.